These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 25288062)

  • 1. [Capecitabine-induced subacute cutaneous lupus: a case report].
    Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
    Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
    Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
    Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
    [No Abstract]   [Full Text] [Related]  

  • 3. Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine.
    Weger W; Kränke B; Gerger A; Salmhofer W; Aberer E
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S4-6. PubMed ID: 18625380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capecitabine-induced subacute cutaneous lupus erythematosus: report of a case with positive rechallenge test.
    Ko JH; Hsieh CI; Chou CY; Wang KH
    J Dermatol; 2013 Nov; 40(11):939-40. PubMed ID: 24111883
    [No Abstract]   [Full Text] [Related]  

  • 5. Subacute cutaneous lupus erythematosus induced by capecitabine.
    Floristan U; Feltes RA; Sendagorta E; Feito-Rodriguez M; Ramírez-Marín P; Vidaurrázaga C; Casado-Jiménez M
    Clin Exp Dermatol; 2009 Oct; 34(7):e328-9. PubMed ID: 19456774
    [No Abstract]   [Full Text] [Related]  

  • 6. Subacute cutaneous lupus erythematosus after treatment with capecitabine.
    Kindem S; Llombart B; Requena C; Ruiz A; Traves V; Guillen C; San Martin O
    J Dermatol; 2013 Jan; 40(1):75-6. PubMed ID: 22937906
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature.
    Shakhbazova A; Marsch AF
    Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
    Almebayadh M; Regnier-Rosencher E; Carlotti A; Goulvestre C; Le Guern V; Mouthon L; Avril MF; Dupin N
    Dermatology; 2013; 226(2):119-23. PubMed ID: 23548825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.
    Marzano AV; Lazzari R; Polloni I; Crosti C; Fabbri P; Cugno M
    Br J Dermatol; 2011 Aug; 165(2):335-41. PubMed ID: 21564069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent.
    Wiznia LE; Subtil A; Choi JN
    JAMA Dermatol; 2013 Sep; 149(9):1071-5. PubMed ID: 23842655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subacute cutaneous lupus erythematosus and cancer: two cases and literature review].
    Gantzer A; Regnier S; Cosnes A; Ortonne N; Wolkenstein P; Bagot M; Duong TA
    Ann Dermatol Venereol; 2011 May; 138(5):409-17. PubMed ID: 21570567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The concurrence of subacute cutaneous lupus erythematosus and hand-foot syndrome in a patient undergoing capecitabine chemotherapy.
    Li Z; Jiang N; Xu Y
    Australas J Dermatol; 2016 Feb; 57(1):e14-6. PubMed ID: 25495707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acebutolol-induced subacute cutaneous lupus erythematosus.
    Fenniche S; Dhaoui A; Ammar FB; Benmously R; Marrak H; Mokhtar I
    Skin Pharmacol Physiol; 2005; 18(5):230-3. PubMed ID: 16015021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine-Induced Subacute Cutaneous Lupus Erythematosus: A Case Report.
    Ben Zvi M; Vaknine H; Menczer J; Peled O; Ben Shem E; Schreiber L; Levy T
    Chemotherapy; 2016; 61(5):236-9. PubMed ID: 26928175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature.
    Lorentz K; Booken N; Goerdt S; Goebeler M
    J Dtsch Dermatol Ges; 2008 Oct; 6(10):823-7, 823-8. PubMed ID: 18564209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic subacute cutaneous lupus erythematosus: an underrecognized entity.
    Evans KG; Heymann WR
    Cutis; 2013 Jan; 91(1):25-9. PubMed ID: 23461055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute coronary syndrome induced by capecitabine therapy.
    Wijesinghe N; Thompson PI; McAlister H
    Heart Lung Circ; 2006 Oct; 15(5):337-9. PubMed ID: 16697705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Subacute cutaneous lupus erythematosus].
    Jore S; Gran JT
    Tidsskr Nor Laegeforen; 1997 May; 117(14):2040-2. PubMed ID: 9235684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subacute cutaneous lupus erythematosus presenting as poikiloderma.
    Hughes R; Loftus B; Kirby B
    Clin Exp Dermatol; 2009 Dec; 34(8):e859-61. PubMed ID: 20055848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paraneoplastic subacute cutaneous lupus erythematosus].
    Rezazadegan R; Koushk-Jalali B; Kuntz T; Oellig F; Tigges C; Kreuter A
    Z Rheumatol; 2021 Mar; 80(2):189-193. PubMed ID: 33236165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.